Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-07

Clinical Trial Update: Bupivacaine HCl PK and Safety in Augmentation Mammoplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the pharmacokinetics and safety of bupivacaine hydrochloride in augmentation mammoplasty, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE)

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 4 | Status: COMPLETED